Chueajedton K, Chueaiphuk C, Inpad J, Kumphune S, et al. Secretory leukocyte protease inhibitor (SLPI) promotes cholangiocarcinoma progression via inflammation-associated and vasculogenic mechanisms. PLoS One 2026;21:e0340763.
PMID: 41557653